Cover Image
市場調查報告書

體外受精 (IVF) 設備及消耗品市場:設備,試劑·培養基,技術,各終端用戶 - 全球機會分析及產業預測

IVF Devices and Consumables Market by Instrument, by Reagent & Media, by Technique, and by End User - Global Opportunity Analysis and Industry Forecast, 2014-2023

出版商 Allied Market Research 商品編碼 563257
出版日期 內容資訊 英文 226 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
體外受精 (IVF) 設備及消耗品市場:設備,試劑·培養基,技術,各終端用戶 - 全球機會分析及產業預測 IVF Devices and Consumables Market by Instrument, by Reagent & Media, by Technique, and by End User - Global Opportunity Analysis and Industry Forecast, 2014-2023
出版日期: 2017年09月01日 內容資訊: 英文 226 Pages
簡介

本報告提供全球體外受精 (IVF) 設備及消耗品市場相關調查,彙整市場趨勢與不同設備,試劑·培養基,各技術,各終端用戶,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 替代技術
  • IVF手術與不孕治療藥及技術性調換
  • IVF手術相關成本
  • IVF市場上捐贈者所扮演的角色
  • 代理母親
  • 同性伴侶的IVF趨勢
  • 最新IVF科技
  • 不孕治療與性別選擇
  • 胚篩檢方法的代謝
  • 幹細胞在IVF上的應用
  • IVF和資源缺乏國家
  • 主要調查結果
  • 波特五力分析
  • 價值鏈分析
  • 專利分析
  • 法律規章的問題
  • 臨床實驗
  • 促進要素
  • 阻礙要素
  • 機會

第4章 不同設備市場

  • 概要
  • 配件及拋棄式

第5章 各試劑·培養基市場

  • 概要
  • 凍結保存培養基
  • 精子處理培養基
  • 卵子處理培養基
  • 胚芽培養基

第6章 各技術市場

  • 概要
  • 新鮮胚芽轉移技術
  • 凍結胚芽轉移技術
  • DONOR EGG IVF技術

第7章 各終端用戶市場

  • 概要
  • 醫院
  • 外科中心
  • 臨床研究機關
  • 診療所

第8章 各地區市場

  • 北美
  • 歐洲
  • 亞太地區
  • 南美

第9章 企業簡介

目錄
Product Code: LI 17124

In-vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the popular treatments, which has assisted couples with infertility problems, single mothers, and the LGBT community to procreate. The global IVF devices and consumables market was valued at $1,506 million in 2016, and is estimated to reach at $4,972 million by 2023, registering a CAGR of 18.3% from 2017 to 2023.

The global IVF devices market is projected to witness a substantial growth in future owing to rise in incidence of infertility cases, emerging trend of delayed pregnancies among women, technological advancements in IVF procedures, and increased occurrences of gamete donations. Furthermore, rise in health awareness on fertility issues, availability of IVF treatments, increase in disposable income and favorable reimbursement policies further augment the market growth.

Recent innovations in IVF technology, such as embryoscope and capsule IVF, are anticipated to augment the demand for IVF devices in future. However, strenuous maintenance issues, high cost of devices, multiple pregnancies, and ethical considerations are anticipated to hinder the market growth. Increase in upsurge of fertility clinics and same sex marriages offer lucrative growth opportunities in future. In addition, fertility tourism provides ample growth opportunities especially in the developing economies.

The global IVF devices and consumables market is segmented into IVF instruments, reagents and media, technique, end users, and geography. The instruments market considered in this report include, sperm separation system, cryosystem, incubator, imaging system, disposables and consumables ovum aspiration pump, IVF cabinet, micromanipulator, IVF accessories and disposables, and others. In the instruments market, micromanipulator generated the highest revenue owing to its extensive use in various stages of the IVF procedure. However, sperm separation system segment witnesses a significant growth due to its extensive use in healthy sperm selection and gender determination. Based on reagents and media, the global IVF devices market is categorized into cryopreservation media, semen processing media, ovum processing media, and embryo culture media.

The IVF devices and consumables market by techniques is categorized into fresh embryo transfer technique, frozen egg transfer technique, and donor egg transfer technique. By end-users, it is categorized into fertility clinics, hospitals, surgical centers, and clinical research institutes. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The report provides extensive competitive analysis and profiles of key market players, such as Cook Medical, Inc., Cooper Companies, Inc., Genea Biomedx, JXTG Holdings, Inc., Merck KGAA, Ovascience, Inc., Oxford Gene Technology, Progyny, Inc. Thermo Fisher Scientific, Inc., and Vitrolife AB. The other players in the value chain include GlaxoSmithKline PLC (Viiv Healthcare Group of Companies), AbbVie Inc., Bristol-Myers Squibb Company, and AstraZeneca plc and others.

KEY BENEFITS FOR STAKEHOLDERS:

  • This report entails a detailed quantitative analysis of the current market trends from 2014 to 2023 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • In-depth analysis based on geography assists to understand the regional market and the strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS:

  • By Instrument
  • Incubators
  • Cryosystem
  • Imaging System
  • Cabinet
  • Ovum Aspiration Pump
  • Sperm Separation System
  • Micromanipulator
  • Accessories and Disposables
  • Others
  • By Reagents & Media
  • Cryopreservation Media
  • Semen Processing Media
  • Ovum Processing Media
  • Embryo Culture Media
  • By Technique
  • Fresh Embryo Transfer Technique
  • Frozen Embryo Transfer Technique
  • Donor Egg IVF Technique
  • By End User
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes
  • By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Rest of Europe
  • Asia-Pacific
  • India
  • China
  • Japan
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Brazil
  • Middle East
  • Africa

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS
  • 1.3. KEY MARKET SEGMENT
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. ALTERNATIVE TECHNOLOGIES
    • 3.2.1. Intrauterine insemination (IUI) technique
      • 3.2.1.1. Factors assessed for the procedure
      • 3.2.1.2. Benefits of this technique
      • 3.2.1.3. Risks
    • 3.2.2. Difference between IUI and IVF technique
    • 3.2.3. GIFT technique
      • 3.2.3.1. Difference between GIFT and IVF technique
    • 3.2.4. ZIFT technique
      • 3.2.4.1. Differences between ZIFT and IVF technique
  • 3.3. REPLACING IVF PROCEDURES BY FERTILITY DRUGS AND SURGERIES
    • 3.3.1. Female infertility treatments
      • 3.3.1.1. Limitations of fertility drugs
    • 3.3.2. Male infertility treatments
  • 3.4. COSTS RELATED TO IVF PROCEDURES
  • 3.5. ROLE OF DONORS IN THE IVF MARKET
    • 3.5.1. Egg donation
    • 3.5.2. Egg sharing
    • 3.5.3. Sperm donation
    • 3.5.4. Embryo donation/adoption
    • 3.5.5. Donation for research
  • 3.6. SURROGACY
    • 3.6.1. Legal issues
  • 3.7. IVF TRENDS IN SAME SEX COUPLES
    • 3.7.1. Artificial insemination
    • 3.7.2. Surrogate mothers
    • 3.7.3. In-vitro fertilization
  • 3.8. ADVANCED IVF TECHNOLOGIES
    • 3.8.1. Capsule IVF
    • 3.8.2. Three parent IVF
      • 3.8.2.1. Ethical concerns
    • 3.8.3. Mini IVF
      • 3.8.3.1. Advantages
      • 3.8.3.2. Drawbacks
    • 3.8.4. Embryo Scope
      • 3.8.4.1. Advantages
    • 3.8.5. PICSI
  • 3.9. FERTILITY TREATMENT AND GENDER SELECTION
    • 3.9.1. Methods of sex selection
      • 3.9.1.1. Gradient method
      • 3.9.1.2. Flow cytometry technique
      • 3.9.1.3. Pre-implantation genetic diagnosis (PGD)
      • 3.9.1.4. Ethical and legal issues
  • 3.10. METABOLOMICS IN EMBRYO SCREENING METHODS
  • 3.11. APPLICATION OF STEM CELLS IN IVF
  • 3.12. IVF AND RESOURCE POOR COUNTRIES
  • 3.13. KEY FINDINGS
    • 3.13.1. Top impacting factors
    • 3.13.2. Top investment pockets
    • 3.13.3. Top winning strategies
  • 3.14. PORTERS FIVE FORCES ANALYSIS
    • 3.14.1. High competition and large number reduces the power of suppliers
    • 3.14.2. Scattered nature and large count of end users moderates the buyer power
    • 3.14.3. High capital cost lowers the threat of new entrants
    • 3.14.4. Industry rivalry is intense due to presence of few dominant competitors
    • 3.14.5. Lack of efficient substitutes lowers the threat from substitutes
  • 3.15. VALUE CHAIN ANALYSIS
  • 3.16. PATENT ANALYSIS
    • 3.16.1. Patent analysis by year
    • 3.16.2. Patents analysis by country
  • 3.17. REGULATORY ISSUES AND LEGISLATIONS
  • 3.18. INSURANCE REIMBURSEMENT SCENARIO
  • 3.19. CLINICAL TRIALS
    • 3.19.1. Trial 1: To study the DHEA outcomes on poor responders of IVF
    • 3.19.2. Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
    • 3.19.3. Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
    • 3.19.4. Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
    • 3.19.5. Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures
  • 3.20. DRIVERS
    • 3.20.1. Delayed pregnancies in women
    • 3.20.2. Rise in global infertility rates
    • 3.20.3. Advancement in technology
    • 3.20.4. Rise in gamete donations
    • 3.20.5. Rise in disposable income
    • 3.20.6. Increase in success rates
  • 3.21. RESTRAINTS
    • 3.21.1. Cost constraints
    • 3.21.2. Ethical and legal issues
    • 3.21.3. Multiple pregnancies
    • 3.21.4. Low awareness level
  • 3.22. OPPORTUNITIES
    • 3.22.1. Fertility tourism
    • 3.22.2. Growing number of fertility clinics
    • 3.22.3. Rise in same sex marriages

CHAPTER 4 IVF DEVICES MARKET, BY INSTRUMENTS

  • 4.1. GLOBAL IVF MARKET BY INSTRUMENTS TYPES, 2014-2023, ($MILLION)
    • 4.1.1. Incubators
      • 4.1.1.1. Global IVF incubators market by region
    • 4.1.2. Cryosystem
      • 4.1.2.1. Global IVF cryosystem market by Region
    • 4.1.3. Imaging system
      • 4.1.3.1. Global IVF Imaging system market by Region
    • 4.1.4. Cabinet (work station)
      • 4.1.4.1. Global IVF cabinets market by Region
    • 4.1.5. Ovum aspiration pump
      • 4.1.5.1. Global IVF ovum aspiration pump market by Region
    • 4.1.6. Sperm separation system
      • 4.1.6.1. Global IVF sperm separation system market by Region
    • 4.1.7. Micro Manipulator System
      • 4.1.7.1. Global IVF Micromanipulator market by Region
    • 4.1.8. Others
      • 4.1.8.1. Global IVF other instruments market by Region
  • 4.2. ACCESSORIES AND DISPOSABLES
    • 4.2.1. Semen analysis chamber
    • 4.2.2. Plastic ware
    • 4.2.3. Oocyte retrieval needles
    • 4.2.4. Miscellaneous disposables
    • 4.2.5. Global IVF accessories and disposables market by region

CHAPTER 5 IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA

  • 5.1. GLOBAL IVF MARKET BY REAGENTS AND MEDIA TYPES, 2014-2023, ($MILLION)
  • 5.2. CRYOPRESERVATION MEDIA
    • 5.2.1. Embryo cryopreservation media
    • 5.2.2. Sperm cryopreservation media
    • 5.2.3. Oocyte cryopreservation media
    • 5.2.4. Global IVF cryopreservation media market by region
  • 5.3. SEMEN PROCESSING MEDIA
    • 5.3.1. Global IVF semen processing media market by region
  • 5.4. OVUM PROCESSING MEDIA
    • 5.4.1. Global IVF ovum processing media market by region
  • 5.5. EMBRYO CULTURE MEDIA
    • 5.5.1. Global IVF embryo culture media market by region

CHAPTER 6 IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE

  • 6.1. GLOBAL IVF MARKET, BY TECHNIQUE, 2014-2023 ($MILLION)
  • 6.2. FRESH EMBRYO TRANSFER TECHNIQUE
    • 6.2.1. Drivers
      • 6.2.1.1. Trends of delayed pregnancies
      • 6.2.1.2. Growing rates of infertility
    • 6.2.2. Restraints
      • 6.2.2.1. Cost involved in the treatment
      • 6.2.2.2. Reimbursements issues with fresh embryo ivf cycles
    • 6.2.3. Global fresh embryo IVF cycle market, by region
  • 6.3. FROZEN EMBRYO TRANSFER TECHNIQUE (FER)
    • 6.3.1. Reasons to use this technique
    • 6.3.2. Advantages of Frozen egg IVF technique
    • 6.3.3. Disadvantages of frozen egg IVF technique
    • 6.3.4. Global frozen egg IVF cycle market, by region
  • 6.4. DONOR EGG IVF TECHNIQUE
    • 6.4.1. Benefits of donor egg IVF technique
    • 6.4.2. Risks associated with donor egg IVF cycle technique
    • 6.4.3. Global donor egg IVF cycle market by region

CHAPTER 7 IVF DEVICES AND CONSUMABLES MARKET BY END USERS

  • 7.1. GLOBAL IVF MARKET BY END USERS, 2014-2023 ($MILLION)
  • 7.2. HOSPITALS
    • 7.2.1. Global IVF hospitals end-user market by Region
  • 7.3. SURGICAL CENTERS
    • 7.3.1. Global IVF surgical centers end-user market by region
  • 7.4. CLINICAL RESEARCH INSTITUTES
    • 7.4.1. Global IVF clinical research institutes end-user market by region
  • 7.5. CLINICS
    • 7.5.1. Global IVF Clinics end-users market by region

CHAPTER 8 IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY

  • 8.1. NORTH AMERICA
    • 8.1.1. North America IVF Devices and Consumables Market, By components
    • 8.1.2. U.S. IVF devices and consumables market
    • 8.1.3. Canada IVF devices and consumables market
    • 8.1.4. Mexico IVF devices and consumables market
  • 8.2. EUROPE
    • 8.2.1. Europe IVF Devices and Consumables Market, By Component
    • 8.2.2. Germany IVF devices and consumables market
    • 8.2.3. France IVF devices and consumables market
    • 8.2.4. UK IVF devices and consumables market
    • 8.2.5. Other Europe IVF devices and consumables market
  • 8.3. ASIA-PACIFIC
    • 8.3.1. Asia-Pacific IVF Devices and Consumables Market, By Component
    • 8.3.2. India IVF devices and consumables market
    • 8.3.3. China IVF devices and consumables market
    • 8.3.4. Japan IVF devices and consumables market
    • 8.3.5. Australia IVF devices and consumables market
    • 8.3.6. Other Asia-Pacific IVF devices and consumables market
  • 8.4. LAMEA
    • 8.4.1. LAMEA IVF Devices and Consumables Market, By Component
    • 8.4.2. Latin America IVF devices and consumables market
      • 8.4.2.1. Brazil IVF devices and consumables market
    • 8.4.3. Middle East IVF devices and consumables market
    • 8.4.4. Africa IVF devices and consumables market

CHAPTER 9 COMPANY PROFILE

  • 9.1. COOK MEDICAL, INC.
    • 9.1.1. Company overview
    • 9.1.2. SWOT analysis of Cook Medical, Inc.
  • 9.2. COOPER COMPANIES, INC. (COOPER SURGICAL, INC.)
    • 9.2.1. Company overview
    • 9.2.2. Business performance
    • 9.2.3. Strategic moves and developments
    • 9.2.4. SWOT analysis of Cooper Surgical, Inc.
  • 9.3. GENEA BIOMEDX
    • 9.3.1. Company overview
    • 9.3.2. Strategic moves and developments
    • 9.3.3. SWOT analysis of Genea Biomedx
  • 9.4. JXTG HOLDINGS, INC.
    • 9.4.1. Company overview
    • 9.4.2. Business performance
    • 9.4.3. Strategic moves and developments
    • 9.4.4. SWOT analysis of JX Holdings
  • 9.5. MERCK KGAA (EMD SERONO, INC.)
    • 9.5.1. Company overview
    • 9.5.2. Business performance
    • 9.5.3. Strategic moves and developments
    • 9.5.4. SWOT analysis of Merck KGaA
  • 9.6. OVASCIENCE INC.
    • 9.6.1. Company overview
    • 9.6.2. Business performance
    • 9.6.3. Strategic moves and developments
    • 9.6.4. SWOT analysis of OvaScience, Inc.
  • 9.7. OXFORD GENE TECHNOLOGY
    • 9.7.1. Company overview
    • 9.7.2. Strategic moves and developments
    • 9.7.3. SWOT analysis of Oxford Gene Technology
  • 9.8. PROGYNY, INC.
    • 9.8.1. Company overview
    • 9.8.2. Strategic moves and developments
    • 9.8.3. SWOT analysis of Progyny, Inc.
  • 9.9. THERMO FISHER SCIENTIFIC INC.
    • 9.9.1. Company overview
    • 9.9.2. Business performance
    • 9.9.3. Strategic moves and developments
    • 9.9.4. SWOT analysis of Thermo Fisher Scientific, Inc.
  • 9.10. VITROLIFE AB
    • 9.10.1. Company overview
    • 9.10.2. Business performance
    • 9.10.3. Strategic moves and developments
    • 9.10.4. SWOT analysis of Vitrolife AB
Back to Top